REG - Caffyns PLC - Directorate Change

CaffynsAnnouncement

04/06/2019 11:20

RNS Number : 0917B
Caffyns PLC
04 June 2019
 


 
4th June 2019
Caffyns plc ("Caffyns" or the "Company")
Appointment of Non-Executive Director
Caffyns is pleased to announce the appointment of Stephen Bellamy as an independent non-executive director of the Company with effect from 18th June 2019. Mr Bellamy will also chair the board's Remuneration Committee and will be a member of its Audit Committee and Nominations Committee.
Nick Hollingworth, having served eleven years as a non-executive director, will retire from the Board at the forthcoming Annual General Meeting on 25 July 2019.
Mr Bellamy has previous experience of motor retail through Brierly Investments where he was Executive Director of their London operation between 1994 and 2000. Mr Bellamy has held numerous non-executive roles and is currently a non-executive director at Advanced Medical Solutions Group plc and Michlemersh Brick Holdings plc.
Commenting on the appointment, Richard Wright, Chairman, said:
"I am delighted to welcome Stephen Bellamy to the Company. He brings with him a wealth of relevant knowledge and experience and strengthens further the Caffyns Board.
I, and the rest of the Caffyns board, would like to take this opportunity to thank Nick Hollingworth for his valuable contribution as a director of the Company over the last 11 years and wish him well for the future"
There are no other matters which require disclosure in respect of Mr Bellamy pursuant to paragraph 9.6.13 (1) to (6) of the Listing Rules of the Financial Conduct Authority.
Enquiries:
Caffyns plc                                                              Tel: 01323 730201
Simon Caffyn, Chief Executive
Mike Warren, Finance Director
 
The HeadLand Consultancy                                    Tel: 0207 367 5228
Francesca Tuckett  
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAEAEKLEFLNEFF